Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-002165

Chief Operating Officer sold 2,271 shares at $5.37 ($12,194)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Bertrand William C JR Chief Operating Officer 2019-01-14 Sale −2,271 $5.37 $12,194 3,731 D
Open-market sales · 2,271 sh · avg $5.37 · $12,194
Loading xslF345X03/a4.xml…